{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:15:08Z","timestamp":1793225708977,"version":"4.5.0"},"reference-count":50,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Vaccines"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.4161\/hv.7.11.17984","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T04:49:19Z","timestamp":1322801359000},"page":"1137-1145","source":"Crossref","is-referenced-by-count":19,"title":["Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable<i>Haemophilus influenzae<\/i>protein D conjugate vaccine (PHiD-CV) in Mexican infants"],"prefix":"10.1080","volume":"7","author":[{"given":"Guillermo M.","family":"Ruiz-Palacios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Lourdes","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Hern\u00e1ndez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lavalle-Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Casas-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Cervantes-Apolinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"R1","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization \u2013 WHO position paper","volume":"82","author":"World Health Organization (WHO)","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"R2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.prrv.2006.04.004","article-title":"Penicillin resistance and serotyping of Streptococcus pneumoniae in Latin America","volume":"7","author":"Camargos","year":"2006","journal-title":"Paediatr Respir Rev"},{"key":"R3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/mdr.1997.3.131","article-title":"Pan American Health Organization epidemiological surveillance network for Streptococcus pneumoniae.","volume":"3","author":"di Fabio","year":"1997","journal-title":"Microb Drug Resist"},{"key":"R4","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/INF.0b013e3181a74b22","article-title":"Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: a SIREVA II project, 2000-2005","volume":"28","author":"Casta\u00f1eda","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1590\/S1020-49892006000500007","article-title":"Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction","volume":"19","author":"Garcia","year":"2006","journal-title":"Rev Panam Salud Publica"},{"key":"R6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"R8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/IAI.59.4.1231-1238.1991","article-title":"Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains","volume":"59","author":"Akkoyunlu","year":"1991","journal-title":"Infect Immun"},{"key":"R9","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1128\/IAI.61.11.4546-4552.1993","article-title":"Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains","volume":"61","author":"Janson","year":"1993","journal-title":"Infect Immun"},{"key":"R10","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/jb.175.14.4569-4571.1993","article-title":"Protein D, a putative immunoglobulin D-binding protein produced by Haemophilus influenzae, is glycerophosphodiester phosphodiesterase","volume":"175","author":"Munson","year":"1993","journal-title":"J Bacteriol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/IAI.63.2.696-699.1995","article-title":"The gene encoding protein D (hpd) is highly conserved among Haemophilus influenzae type b and nontypeable strains","volume":"63","author":"Song","year":"1995","journal-title":"Infect Immun"},{"key":"R12","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1128\/IAI.67.6.2746-2762.1999","article-title":"Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection","volume":"67","author":"Bakaletz","year":"1999","journal-title":"Infect Immun"},{"key":"R13","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1128\/IAI.62.11.4848-4854.1994","article-title":"Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model","volume":"62","author":"Janson","year":"1994","journal-title":"Infect Immun"},{"key":"R14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/314921","article-title":"Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue cultures","volume":"180","author":"Janson","year":"1999","journal-title":"J Infect Dis"},{"key":"R15","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components","volume":"72","author":"Dagan","year":"2004","journal-title":"Infect Immun"},{"key":"R16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates","volume":"7","author":"Dagan","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"R17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"R18","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/INF.0b013e318199f901","article-title":"The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV\/Hib and poliovirus vaccines: assessment of immunogenicity","volume":"28","author":"Bermal","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R19","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/INF.0b013e318199f62d","article-title":"Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines","volume":"28","author":"Chevallier","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R20","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4161\/hv.7.5.14634","article-title":"Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children","volume":"7","author":"Lagos","year":"2011","journal-title":"Hum Vaccin"},{"key":"R22","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R23","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/INF.0b013e318199f609","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines","volume":"28","author":"Wysocki","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R24","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(09)61208-3","article-title":"Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials","volume":"374","author":"Prymula","year":"2009","journal-title":"Lancet"},{"key":"R25","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1097\/INF.0b013e3181b48ca3","article-title":"Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine","volume":"28","author":"Silfverdal","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/INF.0b013e3181f2da06","article-title":"Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with DTPw-HBV\/Hib and poliovirus vaccines","volume":"30","author":"Bermal","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R27","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/INF.0b013e3181dffabf","article-title":"Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months","volume":"29","author":"Vesikari","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R28","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0264-410X(97)00303-4","article-title":"Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile","volume":"16","author":"Hoppenbrouwers","year":"1998","journal-title":"Vaccine"},{"key":"R29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4161\/hv.1.3.1848","article-title":"Lot-to-lot consistency of a combined hexavalent diphtheria-tetanus-acellular-pertussis, hepatitis B, inactivated polio and Haemophilus B conjugate vaccine, administered to healthy Chilean infants at two, four and six months of age","volume":"1","author":"Lagos","year":"2005","journal-title":"Hum Vaccin"},{"key":"R30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.inf.0000050459.74134.d5","article-title":"Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants","volume":"22","author":"Puumalainen","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R31","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jpeds.2010.04.071","article-title":"Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination","volume":"157","author":"V\u00e4kev\u00e4inen","year":"2010","journal-title":"J Pediatr"},{"key":"R32","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/378744","article-title":"Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children","volume":"37","author":"Kilpi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/INF.0b013e31819637af","article-title":"Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Lucero","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R34","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1016\/j.vaccine.2008.05.072","article-title":"Safety and immunogenicity of CRM197-conjugated pneumococcal-meningococcal C combination vaccine (9vPnC-MnCC) whether given in two or three primary doses","volume":"26","author":"Sigurdardottir","year":"2008","journal-title":"Vaccine"},{"key":"R35","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1016\/j.vaccine.2005.06.023","article-title":"Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine","volume":"23","author":"Wuorimaa","year":"2005","journal-title":"Vaccine"},{"key":"R36","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/CVI.00402-10","article-title":"Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines","volume":"18","author":"Poolman","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"R38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2431-10-4","article-title":"Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?","volume":"10","author":"Hausdorff","year":"2010","journal-title":"BMC Pediatr"},{"key":"R39","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/S0264-410X(00)00522-3","article-title":"Peptide and recombinant antigens for protection against bacterial middle ear infection","volume":"19","author":"Bakaletz","year":"2001","journal-title":"Vaccine"},{"key":"R40","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/527396","article-title":"Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines","volume":"46","author":"Forsgren","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R41","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1586\/erv.09.63","article-title":"Chinchilla as a robust, reproducible and polymicrobial model of otitis media and its prevention","volume":"8","author":"Bakaletz","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"R42","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1016\/j.vaccine.2006.03.021","article-title":"Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae.","volume":"24","author":"Novotny","year":"2006","journal-title":"Vaccine"},{"key":"R43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1099\/jmm.0.05007-0","article-title":"Comparative viral frequency in Mexican children under 5 years of age with and without upper respiratory symptoms","volume":"52","author":"Manjarrez","year":"2003","journal-title":"J Med Microbiol"},{"key":"R44","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1016\/j.vaccine.2009.09.111","article-title":"Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease","volume":"27","author":"Hausdorff","year":"2009","journal-title":"Vaccine"},{"key":"R45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"R46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":"Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera","volume":"13","author":"Henckaerts","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R47","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"J\u00f3dar","year":"2003","journal-title":"Vaccine"},{"key":"R48","unstructured":"World Health Organization. Recommendations for the production and control of pneumococcal conjugate vaccines. 2005. Report No. 927, Annex 2."},{"key":"R49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R50","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","article-title":"Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children","volume":"25","author":"Henckaerts","year":"2007","journal-title":"Vaccine"}],"container-title":["Human Vaccines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.7.11.17984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T03:47:25Z","timestamp":1593316045000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/hv.7.11.17984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,10,27]]},"published-print":{"date-parts":[[2011,11]]}},"alternative-id":["10.4161\/hv.7.11.17984"],"URL":"https:\/\/doi.org\/10.4161\/hv.7.11.17984","relation":{},"ISSN":["1554-8600","1554-8619"],"issn-type":[{"value":"1554-8600","type":"print"},{"value":"1554-8619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}